Recombinant epidermal growth factor (Bharat Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant epidermal growth factor (Bharat Biotech)
Drug Alias Name重组人表皮生长因子Recombinant human epidermal growth factorrhuEGFrhEGFhrecEGF +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsBurnsDiabetic Foot
Global Approved IndicationsBurnsDiabetic Foot
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2005/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBharat Biotech International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBharat Biotech International Ltd
Inactive CompaniesN/A
Active IndicationsBurnsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A